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ABSTRACT
As the ﬁrst line of immune defense for Mycobacterium
tuberculosis (Mtb), macrophages also provide a major hab-
itat forMtb toreside inthehost foryears.Thebattlesbetween
Mtb and macrophages have been constant since ancient
times. Triggered upon Mtb infection, multiple cellular path-
ways in macrophages are activated to initiate a tailored
immune response toward the invading pathogen and regu-
late the cellular fates of the host as well. Toll-like receptors
(TLRs) expressed on macrophages can recognize patho-
gen-associated-molecular patterns (PAMPs) on Mtb and
mediate the production of immune-regulatory cytokines
such as tumor necrosis factor (TNF) and type I Interferons
(IFNs). Inaddition,VitaminDreceptor (VDR)andVitaminD-1-
hydroxylase are up-regulated inMtb-infectedmacrophages,
by which Vitamin D participates in innate immune respon-
ses.Thesignalingpathways that involveTNF, type I IFNsand
VitaminDare inter-connected,whichplaycritical roles in the
regulation of necroptosis, apoptosis, and autophagy of the
infected macrophages. This review article summarizes cur-
rent knowledge about the interactions between Mtb and
macrophages, focusing on cellular fates of the Mtb-infected
macrophages and the regulatory molecules and cellular
pathways involved in those processes.
KEYWORDS Mycobacterium tuberculosis,
macrophages, necroptosis, apoptosis, autophagy, tumor
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INTRODUCTION
Approximately one-third of the population in the world are
infected with Mycobacterium tuberculosis (Mtb), If untreated,
one in ten latent infection will progress into active tuberculosis
(TB) disease with about 50% mortality rate. According to the
WHO report, an estimated 8.6million people developedTB, and
1.3 million died from the disease (including 320,000 deaths
among HIV-positive TB patients) in 2012. Furthermore, the glo-
bal estimate of the burden of MDR-TB was 300,000 cases
among notiﬁed TB patients in 2012. India and China were the
two countries estimated to have the largest numbers ofMDR-TB
patients (both over 50,000) (Bogdan, 2000; Gonzalez-Navajas
et al., 2012;WHO, 2013). As an intracellular pathogen,Mtb lives
inmacrophages,whichact as the ﬁrst lineof immunedefense for
Mtb by clearing the pathogen. In the progress of cellular immu-
nity against Mtb, macrophages also function as antigen pre-
senting cells, in which the antigens of Mtb are degraded into
immunogenic polypeptides and presented to T cell by major
histocompatibility complex to trigger adaptive immunity. In turn,
through long battles with host, Mtb has developed a plethora of
strategies to counteract the bactericidal activities of the host
immunity, therebysuccessfullyestablishinganiche for long-term
survival within macrophages (Jayachandran et al., 2013). The
battles between Mtb and macrophages have been constant
since ancient times and become more complicated with the
appearance of drug-resistant Mtb, especially the multidrug-
resistant (MDR) and extensively-drug resistant (XDR) Mtb
(Guirado et al., 2013; Warner and Mizrahi, 2013). In this review,
we summarize current knowledge about the interactions
betweenMtb andmacrophages, focusing on cellular fates of the
infectedmacrophagesand the regulatorymoleculesandcellular
pathways involved in those processes.
MACROPHAGE CELLULAR FATES DURING MTB
INFECTION
Different cellular fates of Mtb-infected macrophages are of
great importance as the death modality inﬂuences the
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outcome of infection. During Mtb infection, several forms of
cellular fates have been observed such as necroptosis,
apoptosis and autophagy, among which apoptosis and
autophagy have been recognized as innate macrophage
defense mechanisms (Behar et al., 2010; Behar et al., 2011;
Bradfute et al., 2013; Du et al., 2013). Apoptotic death
reduces the viability of different mycobacterial species,
including Mtb. The ﬁnding that macrophages infected with
virulent Mtb undergo necroptosis, whereas those infected
with attenuated mutant strains of Mtb undergo apoptosis,
suggests that wild type Mtb actively inhibits apoptosis. Dur-
ing Mtb infection, autophagy represents not only an antimi-
crobial mechanism for the clearance of the intracellular
pathogens, but also prevents excessive inﬂammation,
avoiding the adverse effects on host (Bradfute et al., 2013;
Yu et al., 2013). Results from a genome-wide analysis of the
host intracellular network that regulates survival of Mtb
showed that those factors predominantly function through
the regulation of autophagy (Kumar et al., 2010). In addition,
several studies revealed genetic associations between TB
and host genes involved in autophagy such as the irgm gene
(Songane et al., 2012).
During Mtb infection, multiple molecules and their asso-
ciated signaling pathways in macrophages are involved in
the regulation of cellular fates of host cells. After being
inhaled, Mtb can bind to phagocytic receptors and enters
resident alveolar macrophages recruited from the blood-
stream (Bhatt and Salgame, 2007). Macrophages also
express Toll-like receptors (TLRs) that recognize conserved
pathogen-associated-molecular patterns (PAMPs) on Mtb to
mediate the production of cytokines such as tumor necrosis
factor (TNF) and type I Interferons (IFNs) (Bhatt and Sal-
game, 2007; Hayashi et al., 2001; Killick et al., 2013). TNF
can induce both apoptosis and necroptosis. Type I IFNs can
control Mtb growth as well as cause damage to host cells by
induction of either apoptosis or necroptosis. In addition,
accumulating studies have shown that Vitamin D plays a
vital role in host defense against Mtb by regulating innate
immunity in human macrophages, mainly through induction
of cathelicidin and autophagy (Liu et al., 2006; Shin et al.,
2010).
TNF CAN INDUCE APOPTOSIS AND NECROPTOSIS
OF MTB-INFECTED MACROPHAGES
In Mtb infected macrophages, diverse components derived
from mycobacterial cell walls could stimulate TNF production
through TLR2-mediated signaling pathway (Underhill et al.,
1999). TNF acts on TNF receptors, which exist in soluble or
membrane-bound forms, and further induces host cell
apoptosis (Flynn and Chan, 2001). TNF activates caspase
8-mediated extrinsic cell death pathway involving the kina-
ses ASK1, p38 and c-Abl (Kundu et al., 2009), which lowers
the spread of mycobacteria (Behar et al., 2011). Extracellular
vesicles derived from apoptotic Mtb infected macrophages
carry antigens and can be engulfed by uninfected dendritic
cells, then those antigens are further presented to CD8+ T
cells by MHC-I and CD1, causing activation of T lympho-
cytes and triggering adaptive immunity (Schaible et al.,
2003). Virulent strains such as Mtb H37Rv induce less
macrophage apoptosis than avirulent or attenuated Mtb
strains such as Mtb H37Ra by activating the release of
membrane-bound TNFR2 as the soluble form to evade TNF-
dependent apoptosis (Balcewicz-Sablinska et al., 1998;
Keane et al., 2000; Rakotosamimanana et al., 2013), and by
increasing the expression of Mcl-1 protein that is a member
of anti-apoptotic B-cell lymphoma/leukemia 2 (Bcl-2) family
(Abdallah et al., 2011; Chen et al., 2001; Sly et al., 2003).
The Bcl-2 family proteins, which are located in the outer
membrane of mitochondria, can block the release of cyto-
chrome c from mitochondria (Chen et al., 2001). In addition,
several Mtb gene products can inhibit host cell apoptosis.
For example, nuoG encodes one subunit of the type I NADH
dehydrogenase in Mtb, and over-expression of Mtb nuoG in
the apoptosis-inducing species M. kansasii leads to inhibi-
tion of apoptosis of infected human and murine macro-
phages (Velmurugan et al., 2007). In addition, Mtb can
neutralize NOX2-derived reactive oxigen speices (ROS) in
order to inhibit TNF-mediated host cell apoptosis via
a NuoG-dependent mechanism (Miller et al., 2010). Similar
function can also be observed for PknE and SecA2. Deletion
of pknE results in a mutant that was more susceptible to NO
exposure, and the Mtb pknE mutant induces higher level of
apoptosis than wild type strain (Jayakumar et al., 2008).
secA2 deletion mutant of Mtb induces more apoptosis than
wild type Mtb in infected macrophages (Hinchey et al.,
2007).
TNF is also known to be a potent inducer of mitochondria
ROS. High TNF production induces mitochondrial ROS in
infected macrophages through receptor interacting protein 1
(RIP1)–receptor interacting protein 1 (RIP3)–mixed lineage
kinasedomain-like protein (MLKL)–phosphoglyceratemutase
familymember 5 (PGAM5)–dynamin-related protein-1 (Drp1)-
dependent pathways. While initially increasing macrophage
microbicidal activity, ROS rapidly induces necroptosis during
Mtb infection, resulting in the release of mycobacteria into the
growth-permissive extracellular milieu (Galluzzi and Kro-
emer, 2008; Roca and Ramakrishnan, 2013; Wang et al.,
2012). Necroptosis is a type of programmed necrosis which
acts as a backup to or competitor with apoptosis. A recent
study found that repression of either RIP3 or MLKL could not
protect cells from death but switch TNF-induced necroptosis
toward a delayed RIP1-depend apoptosis (Dondelinger et al.,
2013; Han et al., 2011; Remijsen et al., 2014). After TNF
receptor 1 (TNFR1) is stimulated by TNF, TRADD (TNF
receptor-associated death domain) binds to RIP1, TNF
receptor-associated factor 2/5 (TRAF2/5) and cIAP1/2 (cel-
lular inhibitor of apoptosis 1/2) to form the membrane-proxi-
mal super-molecular structure complex 1 (Han et al., 2011).
Lys 63-linked polyubiquitination of RIP1 or TRAF2 by cIAPs
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results in NF-κB translocation into nucleus to induce tran-
scription of its target genes including A20 and cylindroma-
tosis (CYLD), both of which can deubiquitinate RIP1
(Vandenabeele et al., 2010). Deubiquitination of RIP1 or
inhibition of cIAP proteins promotes the conversion of com-
plex I to complex II, which contains RIP1, FADD, caspase-8
and TRADD (Han et al., 2011). In complex II, caspase-8
becomes activated and initiates apoptosis. If the activity of
caspase-8 is abolished, RIP1 and RIP3 assemble in complex
III with FADD and caspase-8 and, possibly, also TRADD.
Complex III is also called necrosome, in which RIP1 phos-
phorylates RIP3 and further recruits MLKL, leading to nec-
roptosis. Furthermore, activation of deubquitinating enzymes
or the presence of inhibitors of ubiquitinating enzymes keeps
caspase-8 inactive (Vandenabeele et al., 2010). Thus, avir-
ulent Mtb strains are inclined to induce apoptosis, while vir-
ulent Mtb strains tend to switch apoptosis to necroptosis,
which beneﬁts pathogen and contributes to Mtb dissemina-
tion (Jayaraman et al., 2013). We deduce that during certain
stages of infection, virulent Mtb strains might cause higher
expression of TNF than avirulent strains to induce more
necroptosis. Alternatively, virulent strains could, while aviru-
lent strains could not, secrete a biological factor which can
block caspase-8 activity to inhibit apoptosis. Meanwhile, we
do not deny other interpretations for different cellular desti-
nies caused by Mtb strains with different degree of virulence
(Fig. 1).
TYPE I IFNS FUNCTION AS A DOUBLE-EDGED
SWORD DURING MTB INFECTION
IFNs can be divided into three types, including type I IFNs
(IFN-α and IFN-β), type γ IFN (IFN-γ) and type λ IFNs (IFN-
λ1, IFN-λ2 and IFN-λ). Type I IFNs have a pivotal position on
anti-viral immune responses and are important for the host
response against bacterial infection. The production of type I
IFNs leads to protection against some intracellular patho-















































Figure 1. TNF can induce the apoptosis and necroptosis of Mtb-infected macrophages. Mtb cell wall components cause
stimulation of TLR2, which leads to translocation of NF-κB to nucleus and induces expression of TNF through a myeloid differentiation
factor 88 (MyD88)-dependent manner. As TNF binds to TNFR1, TRADD binds to RIP1 and TNFR1 and cIAP1/2 to form complex I.
Lys-63-linked polyubiquitination of RIP1 or TRAF2 by cIAPs results in IκB Lys 63-linked proteasomal degradation. Translocation of
NF-κB into nucleus induces transcription of its target genes including A20 and CYLD. A20 and CYLD deubiquitinate RIP1,which
switches complex I to complex II, then apoptosis is initiated. Upon inactivation of casepase-8, complex III is formed and RIP1 recruits
RIP3, and then RIP3 recruits MLKL, ultimately leading to necroptosis. Mtb can also inhibit apoptosis by up-regulation of Bcl-2 family
protein.
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be mediated through the TLR-dependent recognition of
bacterial products, such as lipopolysaccharide (LPS), or
through the TLR-independent recognition of bacterial ligands
that are delivered to the host cytosol (Gonzalez-Navajas
et al., 2012; Simmons et al., 2010). After the onset of
adaptive immunity, type I IFNs limit the number of myeloid
cells in the lungs, in particular CD11cnegCD11b + Gr-1lo/neg
macrophages, and this initial increased cell populations
promote infection by providing target cells for Mtb intracel-
lular growth (Desvignes et al., 2012). High-mobility group
protein 1 (HMGB1) is a non-histone nuclear protein, which
can be induced to release to outside of the cell by type I
IFNs, and HMGB1 can further induce apoptosis under cer-
tain circumstances such as in the presence of LPS or poly-
inosinic-polycytidylic acid [poly(I:C)] stimulation (Jiang et al.,
2007). In response to type I IFNs, signal transducer and
stimulator of transcription1 (STAT1) can be activated and
form homodimers, then those homodimers could bind to IFN-
γ-activated site (GAS) enhancer elements in the promoters
of IFN-stimulated genes (ISGs), resulting in the induction of
pro-inﬂammatory cytokines or apoptotic factors such as TNF
and NO (van Zoelen et al., 2009; Bordón et al., 2011;
Gonzalez-Navajas et al., 2012). Besides, STAT1–STAT2
heterodimers are activated and bind to IFN regulatory factor
9 (IRF9) in the cytosol to form the IFN-stimulated gene factor
3 (ISGF3) complex, which in turn move to the nucleus to bind
to IFN-stimulated response elements (ISREs) and activate
antiviral or antibacterial genes such as ISGs, leading to the
production of apoptosis-related factors, such as Fas, Fas
ligand (FasL), caspase-4 and caspase-8 (Chawla-Sarkar
et al., 2003; Gonzalez-Navajas et al., 2012). In infected
macrophages, Mtb inhibits IFN-stimulated tyrosine phos-
phorylation of STAT1 to form homodimers and the stimula-
tion of ISGF3 tends to decline in macrophages, while
Mycobacterium bovis BCG can’t inhibit STAT1 homodimers
(Prabhakar et al., 2003).
Type I IFNs has also been shown to exacerbate TB in mice
and to be associated with disease progression in TB patients.
Mtb triggers host type I interferons signaling to reduce the
production of interleukin-1β (IL-1β), a critical mediator of
immunity toMtb (Novikov et al., 2011). Type I IFNs inhibit IL-1β
through two different mechanisms (Guarda et al., 2011). First,
type I IFN activates STAT1, and activated STAT1 directly
abolishes the activity of the NOD-, LRR- and pyrin domain-
containing 1 (NLRP1) and NLRP3 inﬂammasomes, thus
caspase-1-dependent IL-1β maturation is suppressed. Sec-
ond, Type I IFNs induce the production of IL-10, which binds to
receptor in an autocrine manner, leading to decrease of the
level of the precursor, pro-IL-1β, which requires cleavage by
caspase-1 to become its active form. IL-1β can directly kill Mtb
in murine and human macrophages, and it can also kill the
pathogen indirectly through the recruitment of other antimi-
crobial effector molecules. IL-1β directly augments TNF sig-
naling in macrophages through the up-regulation of TNF
secretion and cell surface expression of TNFR1, which results
in activation of caspase-3. Thus, IL-1β and downstream TNF
production lead to caspase-dependent restriction of intracel-
lular Mtb growth (Jayaraman et al.). Virulent mycobacteria
induce higher level of IFN-α/β than avirulent mycobacteria
species (Prabhakar et al., 2003). The increased production of
type I IFNs contribute to increased susceptibility to Mtb,
because IFN-α/β impairs the ability of human macrophage to
control the growth of this pathogen, thus strongly enhances its
replication (Bouchonnet et al., 2002). Type I IFNs could
enhance the susceptibility of mice to infection caused by the
intracellular pathogenS. typhimurium through the induction of
macrophage necroptosis (Liang and Qin, 2013), thus type I
IFNs may also cause macrophage necroptosis during Mtb
infection, which beneﬁt pathogen and contribute to Mtb dis-
semination (Jayaraman et al., 2013). The signaling pathways
leading to IFN-α/β-induced apoptosis and necroptosis are
shown in Fig. 2.
VITAMIN D HELPS COMBAT TB VIA INDUCTION OF
CATHELICIDIN AND AUTOPHAGY
For a long time, Vitamin D is considered critical for bone
metabolism (Mata-Granados et al., 2013). In recent years,
accumulating studies have demonstrated that Vitamin D also
plays a vital role in the regulation of innate immunity in human
macrophages and control of proliferation of Mtb. TLR activation
up-regulates the expression of Vitamin D receptor (VDR) and
Vitamin D-1-hydroxylase, leading to the induction of a peptide,
namely cathelicidin, which can kill intracellular Mtb (Liu et al.,
2006). During early infection, Mtb DNA can strongly stimulate
TLR-9 to inducecathelicidin LL-37 (Rivas-Santiagoet al., 2008).
Cathelicidin not only has direct antimicrobial activity, but also
serves as mediator of 1,25-dihydroxyvitamin D3 (1,25-D3)-
induced autophagy by up-regulation of Beclin (Wu and Sun,
2011). Upon Vitamin D treatment, the expression of mitogen-
activated protein kinase phosphatase-1 (MKP-1) is signiﬁcantly
up-regulated, by which Vitamin D inhibits LPS-induced p38
activation and JNK, leading to subsequent inhibition of pro-
inﬂammatory cytokine production in monocytes and macro-
phages (Zhang et al., 2012). Increased calcium absorption
mediated by the effect of Vitamin D3 on the VDR can activate
autophagy through various calcium-dependent kinases and
phosphatases, while Vitamin D3 can itself down-regulate the
expression of Bcl-2 and mammalian target of rapamycin
(mTOR), a negative regulator of autophagy and Bcl-2. mTOR is
a negative regulator of autophagy, which binds to Beclin 1 and
abolishes the activity of mammalian class III PI3PK complex
(PI3KC3) (Mouli and Ananthakrishnan, 2014; Wu and Sun,
2011). Mycobacterial lipoprotein LpqH stimulates TLR2/1/
CD14, triggering TLR2/1/CD14-Ca2+-AMPK-p38 MAPK path-
ways, contributing to CCAAT/enhancer-binding protein(C/
EBP)-β-dependent expression of D-1-hydroxylase and catheli-
cidinis, which play an essential role in LpqH-induced autophagy
(Shin et al., 2010). 1,25-D3, the active form of Vitamin D, gen-
erally boosts infection-stimulated cytokine and chemokine
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responses and induces the co-localization of mycobacterial
phagosomes with autophagosomes in human macrophages
and synthesis of nitric oxide (NO) synthase that subsequently
produce NO (Rockett et al., 1998; Veyrier et al., 2009; Yuk
et al., 2009). NO can induce mitochondrial permeability tran-
sition and promote apoptosis (Brune, 2003), and it can also
impair autophagy by inhibiting the activity of S-nitrosylation
substrates, JNK1 and IKKβ (Fabri et al., 2011). 1,25-D3 also
can enhance IL-1β expression via a direct transcriptional
mechanism (Verway et al., 2013). Furthermore, Vitamin D is
required for IFN-γ-mediated antimicrobial activity of human
macrophages (Sarkar et al., 2011). The signaling pathways
involved in Vitamin D-induced autophagy are shown in Fig. 3.
A study has shown that TB patients under normal treatment
supplemented with 0.25 mg Vitamin D per day reduced the
time for sputum smear conversion from acid fast bacteria
(AFB) positive to AFB negative (Nursyam et al., 2006).
Ultraviolet-B ray from sunlight triggers synthesis of Vitamin D,
thus TB tends to occur during the colder season when cuta-
neous synthesis of Vitamin D from sun exposure is reduced
and serum Vitamin D levels are lower (Fuchs and Steller,
2011). Humans who lack Vitamin D3 are more likely to be
infected with Mtb. Because of skin melanin content and
diminished ultraviolet (UV) light-dependent cutaneous Vita-
min D3 synthetic capacity, African-Americans have signiﬁ-
cantly decreased level of serum 1,25-D3, and have increased
susceptibility to TB (Liu et al., 2006). Therefore, supplement-
ing with certain amount of Vitamin D and exposure to sunlight
helps combat TB.
SUMMARY AND PERSPECTIVES
Different cellular fates of Mtb-infected macrophages are














































Figure 2. Apoptosis and necroptosis induced by IFN-α/β. Recognition of LPS from Mtb by TLR4 leads to Lys-63-linked
polyubiquitination of TRAF3 (TNF receptor‑associated factor 3), which activates IRF3 (IFN regulatory factor 3). The activated IRF3
enters into nucleus and targets DNA, leading to the expression of IFN-α/β. IFN-α/β then binds to IFN-α/β receptor (IFNR), which
activate JAK1 (Janus kinase 1) and TYK2 (non‑receptor tyrosine kinase 2). The activation of JAK1 and TYR2 can result in
homodimerization of STAT1 and formation of ISGF3. STAT1 homodimers bind to GAS enhancer elements in the promoters of ISGs,
which result in the production of pro-inﬂammatory factors such as TNF and NO, both of which are inducers of apoptosis. ISGF3
migrates to the nucleus to bind to ISGs, leading to the production of apoptosis-related factors. INF-α/β also can mediate necroptosis
by inducing interaction of TNFR1 and RIP1, which promotes formation of RIP1-RIP3 and release of HMGB1 from nucleus to outside
of the cell. The extracellular HMGB1 binds to TLR4 or RAGE (the receptor for advanced glycation end products) to increase the levels
of TNF and NO.
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multiple inter-connected cellular pathways. Programmed cell
death plays a fundamental role that helps maintain cellular
homeostasis, shapes the growth of organism, and provides
protective immunity against invading pathogens (Fuchs and
Steller, 2011). Mtb can induce infected macrophages to
secrete pro-inﬂammatory cytokine TNF, which can trigger
caspase-8-dependent apoptosis. If the activity of caspase-8
is inhibited, apoptosis would be switched to necroptosis.
Virulent Mtb strains induce higher level of TNF than avirulent
or attenuated strains, and excessive TNF induce necropto-
sis, thus virulent strains tend to cause necroptosis. In the
face of apoptosis, virulent Mtb strains have developed a
capacity to disrupt this mechanism, such as expression of
anti-apoptotic Bcl-2 family. Type I IFNs function as a double-
edged sword that both control pathogens and exacerbate
pathogenicity. On the one hand, type I IFNs restrict the
number of myeloid cells in the lungs during early adaptive
immunity, cause translocation of HMGB1 from nucleus to
outside of the cell to induce apoptosis, and result in the
production of pro-inﬂammatory cytokines or apoptotic fac-
tors. On the other hand, type I IFN lowers the level of IL-1β,
increases susceptibility to Mtb, and even may lead to nec-
roptosis. IL-1β can directly kill Mtb in murine and human
macrophages, up-regulate TNF and further induce
apoptosis. 1,25-D3, the active form of Vitamin D, can induce
cathelicidin, which can directly kill intracellular Mtb and
activate autophagy. Besides, 1,25-D3 can also induce the
synthesis of NO synthase to produce NO and up-regulate
IL-1β. Thus the signaling pathways that involve TNF, Type I
IFNs and Vitamin D are inter-connected (Fig. 4). Just like the
way that many food chains constitute a food web, multiple
signaling pathways form a signaling network in macro-
phages. The more complex the signaling network, the
greater the stability of the cellular function. As a result of co-
evolution, the battles between the pathogen and the host
have never stopped and will probably last forever. During
those long-lasting battles, host cells try to keep their stable
function through the complex signaling network, while the
pathogen struggles to survive in the host through disrupting
those cellular pathways.
Pathogens also possess a signaling network, though not
as complex as that of the host. When one pathway is
inhibited, other alternative pathways can compensate for the
normal function of the pathogen, which is one of the major
reasons for pathogen resistance toward antibiotics. Thus, in
recent years, network-based computational biology, with the
emphasis on bio-molecular interactions and omics-data

















Figure 3. Autophagy induced by Vitamin D. After being taken up by the cell, Vitamin D is catalyzed into 1,25-D3 by 25-hydroxylase
and D-1-hydroxylase. 1,25-D3 binds to VDR to activate autophagy through down-regulating mTOR and Bcl-2, and increasing NO,
Ca2+ and cathelicidin. Both JNK1 and DAPK (death-associated kinase) can mediate autophagy by regulating the activity of PI3KC3.
NO impairs the activity of JNK1, and Ca2+ enhances the activity of DAPK. Bcl-2 can bind to Beclin 1 to inhibit the activity of PI3KC3.
Cathelicidin mediates autophagy through increasing Beclin 1. Mtb can induce autophagy by the up-regulation of D-1-hydroxylase,
VDR and cathelicidin, and the down-regulation of Bcl-2. Cathlicidin can be induced by Mtb DNA-mediated stimulation of TLR9.
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drug cocktails for the treatment of intractable pathogens
such as Mtb. Such kind of treatment strategy could not only
alleviate the problems of the recurrent emergence of drug
resistance but also reveal their synergistic effects (Ander-
sen, 1997; Wu et al., 2013). We hold an opinion that multiple
drugs should be aimed at relevant sites instead of arbitrary
targets so that the pathogens could not escape from alter-
native pathways. In addition, the multi-drug therapy should
enhance beneﬁcial signaling pathways while abolishing
harmful pathways in host cells in order to alleviate side
effects. For example, most vaccine candidates for TB are
screened for their capacity to induce multi-functional T cells
capable of producing TNF, since high TNF production could
cause necroptosis (van Heijst and Pamer, 2013), thus
repression of RIP3 or MLKL should be considered to switch
TNF-induced necroptosis toward RIP1-dependent apoptosis
in the presence of excessive TNF. With increasing knowl-
edge on molecular details involved in Mtb-host interactions
as well as mechanisms of drug action, we ﬁrmly believe that
more effective multi-drug therapies for the treatment of Mtb
including drug-resistant Mtb would be more widely adopted
in the near future.
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